USA Financial Formulas’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21
| Closed | -$1.22K | – | 370 |
|
|
2023
Q3 | $1.22K | Hold |
21
| – | – | ﹤0.01% | 388 |
|
|
2023
Q2 | $1.34K | Hold |
21
| – | – | ﹤0.01% | 350 |
|
|
2023
Q1 | $1.46K | Buy |
+21
| New | +$1.46K | ﹤0.01% | 263 |
|
|
2022
Q3 | $17K | Buy |
240
+200
| +500% | +$14.2K | 0.03% | 100 |
|
|
2022
Q2 | $3K | Sell |
40
-5
| -11% | -$375 | ﹤0.01% | 172 |
|
|
2022
Q1 | $3K | Hold |
45
| – | – | ﹤0.01% | 198 |
|
|
2021
Q4 | $3K | Sell |
45
-787
| -95% | -$52.5K | ﹤0.01% | 238 |
|
|
2021
Q3 | $49K | Buy |
832
+787
| +1,749% | +$46.4K | 0.04% | 206 |
|
|
2021
Q2 | $3K | Buy |
45
+4
| +10% | +$267 | ﹤0.01% | 283 |
|
|
2021
Q1 | $3K | Sell |
41
-1,277
| -97% | -$93.4K | ﹤0.01% | 247 |
|
|
2020
Q4 | $82K | Buy |
1,318
+1,264
| +2,341% | +$78.6K | 0.06% | 153 |
|
|
2020
Q3 | $3K | Buy |
54
+41
| +315% | +$2.28K | ﹤0.01% | 193 |
|
|
2020
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 148 |
|
|
2020
Q1 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 179 |
|
|
2019
Q1 | – | Sell |
-8,884
| Closed | -$552K | – | 146 |
|
|
2018
Q4 | $552K | Buy |
+8,884
| New | +$552K | 0.14% | 118 |
|
|
2016
Q3 | – | Sell |
-11,798
| Closed | -$868K | – | 235 |
|
|
2016
Q2 | $868K | Buy |
+11,798
| New | +$868K | 0.24% | 88 |
|
|
2015
Q3 | – | Sell |
-61,269
| Closed | -$4.08M | – | 106 |
|
|
2015
Q2 | $4.08M | Buy |
+61,269
| New | +$4.08M | 1.25% | 20 |
|